In many APAC markets where healthcare spending is largely out of pocket, adoption tends to be slower, explains FMCG consultant Veena Giridhar-Gopal, adding that the demand profile has traditionally differed from that of western markets
PMC 4912877
Nikolaidis LA, Elahi D, Hentosz T, Doverspike A, Huerbin R, Zourelias L, Stolarski C, Shen YT, Shannon RP
Other Qsymia interactions include central nervous system (CNS) depressants, amitriptyline, and certain anticonvulsants, among others
Recent gene profiling studies using the Broad Institute's Connectivity Map have revealed that GHK modulates expression of approximately 31.2% of human genes, with 59% being upregulated and 41% downregulated
Manufactured in the UK to GMP standards